Acomplia likely to be launched in Europe or Mexico prior to the U.S.
With the delay of approval of Acomplia (rimonabant) by FDA for sale of the weight loss drug in the U.S., Sanofi-Aventis, the maker of the drug is apparently hoping to launch the highly anticipated weight-loss drug in Europe and Mexico during the second half of this year. Read More...

Approval delayed for eagerly awaited Acomplia
Acomplia, the approvable and eagerly awaited weight loss drug which was likely to get FDA approval within months now appears to be facing a delay. Read More...

Acomplia shows promise
Diet pill Acomplia is going to be the next big pharmaceutical blockbuster according to a latest study which showed promising results for Acomplia (Rimonabant). Read More...

Diet pill Acomplia keeps weight off
A recent study suggests that the weight loss drug Acomplia by Sanofi-Aventis' can help obese people to lose weight and keep it off for at least two years if not more. Read More...

Indian pharma plans clinical trials for a drug similar to Acomplia
An Indian pharma company known as Glenmark Pharmaceuticals, Ltd. had announced on Feb. 13, 2006 that it is planning to begin clinical trials of a new diet pill that works in a much similar manner to the much anticipated drug Acomplia. Read More...

Acomplia has the potential to beat the diet pill curse
Diet pills are an easy way to lose weight and that's why they've been greeted with such enthusiasm over the years. Read More...

Schools target for obesity control
Schools across the nation of Australia will be forced to keep junk food out of tuck shops under a Howard Government plan to combat obesity and weight-related diseases. Read More...

Abnormal brain hormone increases the chances of obesity
According to latest findings, it has been noticed that an abnormal brain hormone may increase the risk of obesity. The findings could lead to the development of a drug to treat certain cases of obesity. Read More...